The anatomy of cognitive impairment in amyotrophic lateral sclerosis: More than frontal lobe dysfunction

Cortex

Volumn 48, Issue 2, 2012, Pages 166-182

  Tsermentseli, Stella ^a   Leigh, P Nigel ^a   Goldstein, Laura H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Cognitive impairment; Frontotemporal dementia; Neuroimaging; Neuropathology

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TAR DNA BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; BEHAVIOR DISORDER; BRAIN ATROPHY; CLINICAL FEATURE; COGNITIVE DEFECT; DIFFUSION TENSOR IMAGING; FRONTAL CORTEX; FRONTAL LOBE; FRONTOTEMPORAL DEMENTIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LIMBIC CORTEX; MEMORY; NEUROANATOMY; NEUROIMAGING; NEUROPSYCHOLOGY; POSITRON; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOMATOSENSORY CORTEX; TASK PERFORMANCE; TEMPORAL CORTEX; VOXEL BASED MORPHOMETRY; WHITE MATTER;

AMYOTROPHIC LATERAL SCLEROSIS; BEHAVIOR; COGNITION DISORDERS; DIFFUSION TENSOR IMAGING; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; TEMPORAL LOBE;

EID: 84856220417     PISSN: 00109452     EISSN: 19738102     Source Type: Journal    
DOI: 10.1016/j.cortex.2011.02.004     Document Type: Review

References (140)

1. Abe K., Fujimura H., Toyooka K., Sakoda S., Yorifuji S., Yanagihara T. Cognitive function in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 1997, 148(1):95-100.
2. Abrahams S., Goldstein L.H., Al Chalabi A., Pickering A., Morris R.G., Passingham R.E., et al. Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1997, 62(5):464-472.
3. Abrahams S., Goldstein L.H., Kew J.J., Brooks D.J., Lloyd C.M., Frith C.D., et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain 1996, 119(6):2105-2120.
4. Abrahams S., Goldstein L.H., Simmons A., Brammer M., Williams S.C., Giampietro V., et al. Word retrieval in amyotrophic lateral sclerosis: A functional magnetic resonance imaging study. Brain 2004, 127(7):1507-1517.
5. Abrahams S., Goldstein L.H., Simmons A., Brammer M.J., Williams S.C., Giampietro V.P., et al. Functional magnetic resonance imaging of verbal fluency and confrontation naming using compressed image acquisition to permit overt responses. Human Brain Mapping 2003, 20(1):29-40.
6. Abrahams S., Goldstein L.H., Suckling J., Simmons A., Ng V., Giampietro V., et al. Frontotemporal white matter changes in amyotrophic lateral sclerosis. Journal of Neurology 2005, 252(3):321-331.
7. Abrahams S., Leigh P.N., Harvey A., Vythelingum G.N., Grise D., Goldstein L.H. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia 2000, 38(6):734-747.
8. Abrahams S., Leigh P.N., Kew J.J., Goldstein L.H., Lloyd C.M., Brooks D.J. A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 1995, 129S:44-46.
9. Agosta F., Pagani E., Petrolini M., Caputo D., Perini M., Prelle A., et al. Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: A diffusion tensor MR imaging tractography study. American Journal of Neuroradiology 2010, 31(8):1457-1461.
10. Agosta F., Pagani E., Rocca M.A., Caputo D., Perini M., Salvi F., et al. Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Human Brain Mapping 2007, 28(12):1430-1438.
11. al Sarraj S., Maekawa S., Kibble M., Everall I., Leigh N. Ubiquitin-only intraneuronal inclusion in the substantia nigra is a characteristic feature of motor neurone disease with dementia. Neuropathology and Applied Neurobiology 2002, 28(2):120-128.
12. Anderson V.E., Cairns N.J., Leigh P.N. Involvement of the amygdala, dentate and hippocampus in motor neuron disease. Journal of the Neurological Sciences 1995, 129(Suppl):75-78.
13. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochemical and Biophysical Research Communications 2006, 351(3):602-611.
14. Ashburner J., Friston K.J. Voxel-based morphometry - the methods. NeuroImage 2000, 11(6):805-821.
15. Bak T.H., Hodges J.R. Noun-verb dissociation in three patients with motor neuron disease and aphasia. Brain and Language 1997, 60:38-41.
16. Bak T.H., Hodges J.R. Motor neurone disease, dementia and aphasia: coincidence, co-occurence or continuum?. Journal of Neurology 2001, 248(4):260-270.
17. Bak T.H., O'Donovan D.G., Xuereb J.H., Boniface S., Hodges J.R. Selective impairment of verb processing associated with pathological changes in Brodmann areas 44 and 45 in the motor neurone disease-dementia-aphasia syndrome. Brain 2001, 124(1):103-120.
18. Berthier M.L., Lambon Ralph M.A., Pujol J., Green C. Arcuate fasciculus variability and repetition: The left sometimes can be right. Cortex 2012, 48(2):133-143.
19. Bizzi A., Nava S., Ferrè F., Castelli G., Aquino D., Ciaraffa F., et al. Gliomas infiltrating the ventrolateral frontal region: clinical anatomo-functional language assessment with neuropsychology, diffusion MR tractography and functional MR imaging. Cortex 2012, 48(2):255-272.
20. Blain C.R., Williams V.C., Johnston C., Stanton B.R., Ganesalingam J., Jarosz J.M., et al. A longitudinal study of diffusion tensor MRI in ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2007, 8(6):348-355.
21. Bowen D.M., Procter A.W., Mann D.M., Snowden J.S., Esiri M.M., Neary D., et al. Imbalance of a serotonergic system in frontotemporal dementia: Implication for pharmacotherapy. Psychopharmacology (Berlin) 2008, 196(4):603-610.
22. Caramazza A., Hillis A. Lexical organization of nouns and verbs in the brain. Nature 1991, 349:788-790.
23. Caselli R.J., Smith B.E., Osborne D. Primary lateral sclerosis: A neuropsychological study. Neurology 1995, 45(11):2005-2009.
24. Caselli R.J., Windebank A.J., Petersen R.C., Komori T., Parisi J.E., Okazaki H., et al. Rapidly progressive aphasic dementia andmotor neuron disease. Annals of Neurology 1993, 34(3):200-207.
25. Catani M., Dell'Acqua F., Vergani F., Malik F., Hodge H., Roy P., et al. Short frontal lobe connections of the human brain. Cortex 2012, 48(2):273-291.
26. Catani M. Diffusion tensor magnetic resonance imaging tractography in cognitive disorders. Current Opinion in Neurology 2006, 19(6):599-606.
27. Catani M., ffytche D. The rise and fall of disconnection syndromes. Brain 2005, 128(10):2224-2239.
28. Catani M., Jones D.K., ffytche D.H. Perisylvian language networks of the human brain. Annals of Neurology 2005, 57(1):8-16.
29. Catani M., Piccirilli M., Geloso M.C., Cherubino A., Finali G., Pelliccioli G., et al. Rapidly progressive aphasic dementia with motor neuron disease: A distinctive clinical entity. Dementia and Geriatric Cognitive Disorders 2004, 17(1-2):21-28.
30. Cedarbaum J.M., Stambler N., Malta E., Fuller C., Hilt D., Thurmond B., et al. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). Journal of the Neurological Sciences 1999, 169(1-2):13-21.
31. Chang J.L., Lomen-Hoerth C., Murphy J., Henry R.G., Kramer J.H., Miller B.L., et al. A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology 2005, 65(1):75-80.
32. Charcot J.M., Joffroy A. Deux cas d'atrophie musculaire progresive avec les lesions de la substance grise et faisceaux antero-lateraux de la moelle épinière. Archives de Physiologie Normale et Pathologique 1869, 2:354-367.
33. Ciccarelli O., Behrens T.E., Johansen-Berg H., Talbot K., Orrell R.W., Howard R.S., et al. Investigation of white matter pathology in ALS and PLS using tract-based spatial statistics. Human Brain Mapping 2009, 30(2):615-624.
34. Cobble M. Language impairment in motor neurone disease. Journal of the Neurological Sciences 1998, 160(S1):47-52.
35. Constantinidis J., Tissot R. Generalized Alzheimer's neurofibrillary lesions without senile plaques. (Presentation of one anatomo-clinical case). Schweizer Archiv für Neurologie, Neurochirurgie und Psychiatrie 1967, 100(1):117-130.
36. David A.S., Gillham R.A. Neuropsychological study of motor neuron disease. Psychosomatics 1986, 27(6):441-445.
37. Diehl B., Busch R.M., Duncan J.S., Piao Z., Tkach J., Luders H.O. Abnormalities in diffusion tensor imaging of the uncinate fasciculus relate to reduced memory in temporal lobe epilepsy. Epilepsia 2008, 49(8):1409-1418.
38. Doran M., Xuereb J.H., Hodges J.R. Rapidly progressive aphasia with bulbar motor neurone disease: A clinical and neuropsychological study. Behavioural Neurology 1995, 8:169-180.
39. Ellis C.M., Simmons A., Jones D.K., Bland J., Dawson J.M., Horsfield M.A., et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 1999, 53(1):1051-1058.
40. Ellis C.M., Suckling J., Amaro E., Bullmore E.T., Simmons A., Williams S.C., et al. Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS. Neurology 2001, 57(9):1571-1578.
41. Evdokimidis I., Constantinidis T.S., Gourtzelidis P., Smyrnis N., Zalonis I., Zis P.V., et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 2002, 195(1):25-33.
42. Frank B., Haas J., Heinze H.J., Stark E., Munte T.F. Relation of neuropsychological and magnetic resonance findings in amyotrophic lateral sclerosis: Evidence for subgroups. Clinical Neurology and Neurosurgery 1997, 99(2):79-86.
43. Friston K.J., Frith C.D., Liddle P.F., Frackowiak R.S. Comparing functional (PET) images: The assessment of significant change. Journal of Cerebral Blood Flow and Metabolism 1991, 11(4):690-699.
44. Furukawa T. Clinical and epidemiological studies on amyotrophic lateral sclerosis. Osaka Daigaku Igaku Zasshi 1959, 11:4087-4099. [inJapanese].
45. Gallassi R., Montagna P., Morreale A., Lorusso S., Tinuper P., Daidone R., et al. Neuropsychological, electroencephalogram and brain computed tomography findings in motor neuron disease. European Neurology 1989, 29(2):115-120.
46. Gaudette M., Hirano M., Siddique T. Current status of SOD1 mutations in familial amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2000, 1(2):83-89.
47. Geser F., Brandmeir N.J., Kwong L.K., Martinez-Lage M., Elman L., McCluskey L., et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Archives of Neurology 2008, 65(5):636-641.
48. Geser F., Martinez-Lage M., Robinson J., Uryu K., Neumann M., Brandmeir N.J., et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Archives of Neurology 2009, 66(2):180-189.
49. Goldstein L.H., Leigh P.N. Motor neurone disease: A review of its emotional and cognitive consequences for patients and its impact on carers. British Journal of Health Psychology 1999, 4(3):193-208.
50. Graham J.M., Papadakis N., Evans J., Widjaja E., Romanowski C.A., Paley M.N., et al. Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology 2004, 63(11):2111-2119.
51. Grosskreutz J., Kaufmann J., Fradrich J., Dengler R., Heinze H.J., Peschel T. Widespread sensorimotor and frontal cortical atrophy in amyotrophic lateral sclerosis. BMC Neurology 2006, 6:17.
52. Grossman M., Anderson C., Khan A., Avants B., Elman L., McCluskey L. Impaired action knowledge in amyotrophic lateral sclerosis. Neurology 2008, 71(18):1396-1401.
53. Hanagasi H.A., Gurvit I.H., Ermutlu N., Kaptanoglu G., Karamursel S., Idrisoglu H.A., et al. Cognitive impairment in amyotrophic lateral sclerosis: Evidence from neuropsychological investigation and event-related potentials. Cognitive Brain Research 2002, 14(2):234-244.
54. Hodges J.R., Miller B. The classification, genetics and neuropathology of frontotemporal dementia. Introduction to the special topic papers: Part I. Neurocase 2001, 7(1):31-35.
55. Hong Y.H., Lee K.W., Sung J.J., Chang K.H., Song I.C. Diffusion tensor MRI as a diagnostic tool of upper motor neuron involvement in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 2004, 227(1):73-78.
56. Horoupian D.S., Thal L., Katzman R., Terry R.D., Davies P., Hirano A., et al. Dementia and motor neuron disease: Morphometric, biochemical, and Golgi studies. Annals of Neurology 1984, 16(3):305-313.
57. Hudson A.J. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: Areview. Brain 1981, 104(2):217-247.
58. Ishikawa T., Morita M., Nakano I. Constant blood flow reduction in premotor frontal lobe regions in ALS with dementia - a SPECT study with 3D-SSP. Acta Neurologica Scaninavica 2007, 116(5):340-344.
59. Jones D., Symms M., Cercignani M., Howard R. The effect offilter size on VBM analyses of DT-MRI data. NeuroImage 2005, 26(2):546-554.
60. Josephs K.A., Knopman D.S., Whitwell J.L., Boeve B.F., Parisi J.E., Petersen R.C., et al. Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND. Neurology 2005, 65(4):645-647.
61. Kassubek J., Unrath A., Huppertz H.J., Lule D., Ethofer T., Sperfeld A.D., et al. Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2005, 6(4):213-220.
62. Kato S., Hayashi H., Yagishita A. Involvement of the frontotemporal lobe and limbic system in amyotrophic lateral sclerosis: As assessed by serial computed tomography and magnetic resonance imaging. Journal of the Neurological Sciences 1993, 116(1):52-58.
63. Kawashima T., Doh-ura K., Kikuchi H., Iwaki T. Cognitive dysfunction in patients with amyotrophic lateral sclerosis is associated with spherical or crescent-shaped ubiquitinated intraneuronal inclusions in the parahippocampal gyrus and amygdala, but not in the neostriatum. Acta Neuropathologica (Berlin) 2001, 102(5):467-472.
64. Kew J.J., Leigh P.N., Playford E.D., Passingham R.E., Goldstein L.H., Frackowiak R.S., et al. Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain 1993, 116(3):655-680.
65. Kew J.J., Goldstein L.G., Leigh P.N., Abrahams S., Cosgrave N., Passingham R.E., et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis: A neuropsychological and positron emission study. Brain 1993, 116(6):1399-1423.
66. Kiernan J.A., Hudson A.J. Frontal lobe atrophy in motor neuron diseases. Brain 1994, 117(4):747-757.
67. Kilani M., Micallef J., Soubrouillard C., Rey-Lardiller D., Demattei C., Dib M., et al. A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2004, 5(1):46-54.
68. Lanctôt K.L., Herrmann N., Ganjavi H., Black S.E., Rusjan P.M., Houle S., et al. Serotonin-1A receptors in frontotemporal dementia compared with controls. Psychiatry Research: NeuroImaging 2007, 156(3):247-250.
69. Le Forestier N., Maisonobe T., Piquard A., Rivaud S., Crevier-Buchman L., Salachas F., et al. Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain 1989-1999, 2001, 124(10).
70. Lloyd C.M., Richardson M.P., Brooks D.J., Al Chalabi A., Leigh P.N. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain 2000, 123(11):2289-2296.
71. Ludolph A.C., Langen K.J., Regard M., Herzog H., Kemper B., Kuwert T., et al. Frontal lobe function in amyotrophic lateral sclerosis: A neuropsychologic and positron emission tomography study. Acta Neurologica Scandinavica 1992, 85(2):81-89.
72. Lulé D., Diekmann V., Anders S., Kassubek J., Kubler A., Ludolph A.C., et al. Brain responses to emotional stimuli in patients with amyotrophic lateral sclerosis (ALS). Journal of Neurology 2007, 254(4):519-527.
73. Lulé D., Diekmann V., Müller H.P., Kassubek J., Ludolph A.C., Birbaumer N. NeuroImaging of multimodal sensory stimulation in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 2010, 81(8):899-906.
74. Lund and Manchester groups Consensus statement. Clinical andneuropathological criteria for fronto-temporal dementia. Journal of Neurology, Neurosurgery and Psychiatry 1994, 4:416-418.
75. Mackenzie I.R., Bigio E.H., Ince P.G. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Annals of Neurology 2007, 61(5):427-434.
76. Maekawa S., al Sarraj S., Kibble M., Landau S., Parnavelas J., Cotter D., et al. Cortical selective vulnerability in motor neuron disease: A morphometric study. Brain 2004, 127(6):1237-1251.
77. Mantovan M.C., Baggio L., Dalla B.G., Smith P., Pegoraro E., Soraru' G., et al. Memory deficits and retrieval processes in ALS. European Journal of Neurology 2003, 10(3):221-227.
78. Massman P.J., Sims J., Cooke N., Haverkamp L.J., Appel V., Appel S.H. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1996, 61(5):450-455.
79. McKenna P., Warrington E.K. Graded Naming Test 1983, NFER-Nelson.
80. Mezzapesa D.M., Ceccarelli A., Dicuonzo F., Carella A., De Caro M.F., Lopez M., et al. Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. American Journal of Neuroradiology 2007, 28:255-259.
81. Minnerop M., Specht K., Ruhlmann J., Grothe C., Wüllner U., Klockgether T. Invivo voxel-based relaxometry in amyotrophic lateral sclerosis. Journal of Neurology 2009, 256(1):28-34.
82. Mitsuyama Y., Takamiya S. Presenile dementia with motor neuron disease in Japan. A new entity?. Archives of Neurology 1979, 36(9):592-593.
83. Mohammadi B., Kollewe K., Samii A., Krampfl K., Dengler R., Munte T. Changes of resting state networks in amyotrophic lateral sclerosis. Experimental Neurology 2009, 217(1):147-153.
84. Murphy J.M., Henry R.G., Langmore S., Kramer J.H., Miller B.L., Lomen-Hoerth C. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Archives of Neurology 2007, 64(4):530-534.
85. Murtha S., Chertkow H., Beauregard M., Evans A. The neural substrate of picture naming. Journal of Cognitive Neuroscience 1999, 11(4):399-423.
86. Nagano Y., Kondo K., Tsubaki T. Amyotrophic lateral sclerosis - with special reference to statistical data of clinical manifestations. Shinkei Shinpo 1977, 21:340-347. [in Japanese].
87. Nakano I. Frontotemporal dementia with motor neuron disease (amyotrophic lateral sclerosis with dementia). Neuropathology 2000, 20(1):68-75.
88. Neary D., Snowden J.S., Mann D.M. Cognitive change in motor neurone disease/amyotrophic lateral sclerosis (MND/ALS). Journal of the Neurological Sciences 2000, 180(1-2):15-20.
89. Neary D., Snowden J.S., Gustafson L., Passant U., Stuss D., Black S., et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998, 51(6):1546-1554.
90. Neary D., Snowden J.S., Mann D.M., Northen B., Goulding P.J., McDermott N. Frontal lobe dementia and motor neuron disease. Journal of Neurology, Neurosurgery and Psychiatry 1990, 53(1):23-32.
91. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
92. Neumann M. Molecular neuropathology of TDP-43 proteinopathies. International Journal of Molecular Sciences 2009, 10(1):232-246.
93. Newsom-Davis I.C., Abrahams S., Goldstein L.H., Leigh P.N. The emotional lability questionnaire: A new measure of emotional lability in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 1999, 169(1):22-25.
94. Olney R.K., Murphy J., Forshew D., Garwood E., Miller B.L., Langmore S., et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology 2005, 65(11):1774-1777.
95. Palmieri A., Naccarato M., Bonato M., D'Ascenzo C., Balestreri S., Cima V., et al. Right hemisphere dysfunction and emotional processing in ALS: An fMRI study. Journal of Neurology 2010, 257(12):1970-1978.
96. Paulesu E., Frith C.D., Frackowiak R.S. The neural correlates of the verbal component of working memory. Nature 1993, 362:342-345.
97. Phukan J., Pender N.P., Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurology 2007, 6(11):994-1003.
98. Pinkhardt E.H., Jurgens R., Becker W., Molle M., Born J., Ludolph A.C., et al. Signs of impaired selective attention in patients with amyotrophic lateral sclerosis. Journal of Neurology 2008, 255(4):532-538.
99. Piquard A., Le Forestier N., Baudoin-Madec V., Delgadillo D., Salachas F., Pradat P.F., et al. Neuropsychological changes in patients with primary lateral sclerosis. Amyotrophic Lateral Sclerosis 2006, 7(3):150-160.
100. Portet F., Cadilhac C., Touchon J., Camu W. Cognitive impairment in motor neuron disease with bulbar onset. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2001, 2(1):23-29.
101. Raaphorst J., de Visser M., van Tol M., Linssen W.H.J.P., van der Kooi A.J., de Haan R.J., et al. Cognitive disfunction in lower motor neuron disease: Executive and memory deficits in progressive muscular atrophy. Journal of Neurology, Neurosurgery and Psychiatry 2011, 82(2):170-175.
102. Rafalowska J., Dziewulska D. White matter injury in amyotrophic lateral sclerosis (ALS). Folia Neuropathology 1996, 34(2):87-91.
103. Rakowicz W.P., Hodges J.R. Dementia and aphasia in motor neuron disease: An underrecognised association?. Journal of Neurology, Neurosurgery and Psychiatry 1998, 65(6):881-889.
104. Reed D.M., Brody J.A. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945-1972. I. Descriptive epidemiology. American Journal of Epidemiology 1975, 101(4):287-301.
105. Ringholz G.M., Appel S.H., Bradshaw M., Cooke N.A., Mosnik D.M., Schulz P.E. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005, 65(4):586-590.
106. Sach M., Winkler G., Glauche V., Liepert J., Heimbach B., Koch M.A., et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 2004, 127(2):340-350.
107. Sage C.A., Peeters R.R., Gorner A., Robberecht W., Sunaert S. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis. NeuroImage 2007, 34(2):486-499.
108. Sage C.A., Van H.W., Peeters R., Sijbers J., Robberecht W., Parizel P., et al. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: Revisited. Human Brain Mapping 2009, 30(11):3657-3675.
109. Sato K., Aoki S., Iwata N.K., Masutani Y., Watadani T., Nakata Y., et al. Diffusion tensor tract-specific analysis of the uncinate fasciculus in patients with amyotrophic lateral sclerosis. Neuroradiology 2010, 52(8):729-733.
110. Schoenfeld M.A., Tempelmann C., Gaul C., Kuhnel G.R., Duzel E., Hopf J.M., et al. Functional motor compensation in amyotrophic lateral sclerosis. Journal of Neurology 2005, 252(8):944-952.
111. Smith C.D., Andersen A.H., Chen Q., Blonder L.X., Kirsch J.E., Avison M.J. Cortical activation in confrontation naming. NeuroReport 1996, 29(7):781-785.
112. Stanton B.R., Shinhmar D., Turner M.R., Williams V.C., Williams S.C.R., Blain C.R.V., et al. Diffusion tensor imaging in sporadic and familial (D90A SOD1) forms of amyotrophic lateral sclerosis. Archives of Neurology 2009, 66(1):109-115.
113. Stanton B.R., Williams V.C., Leigh P.N., Williams S.C., Blain C.R., Jarosz J.M., et al. Altered cortical activation during a motor task in ALS. Evidence for involvement of central pathways. Journal of Neurology 2007, 254(9):1260-1267.
114. Stanton B.R., Williams C.V., Leigh P.N., Williams S.C., Blain C.R., Giampietro P.V., et al. Cortical activation during motor imagery is reduced in amyotrophic lateral sclerosis. Brain Research 2007, 1172:145-151.
115. Strong M.J., Grace G.M., Orange J.B., Leeper H.A., Menon R.S., Aere C. A prospective study of cognitive impairment in ALS. Neurology 1999, 53(8):1665-1670.
116. Strong M.J., Grace G.M., Freedman M., Lomen-Hoerth C., Woolley S., Goldstein L.H., et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 2009, 10(4):131-146.
117. Talbot P.R., Goulding P.J., Lloyd J.J., Snowden J.S., Neary D., Testa H.J. Inter-relation between " classic" motor neuron disease and frontotemporal dementia: Neuropsychological and single photon emission computed tomography study. Journal of Neurology, Neurosurgery and Psychiatry 1995, 58(5):541-547.
118. Tan C.F., Eguchi H., Tagawa A., Onodera O., Iwasaki T., Tsujino A., et al. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathologica 2007, 113(5):535-542.
119. Thiebaut de Schotten M., Dell'Acqua F., Valabregue R., Catani M. Monkey to human comparative anatomy of thefrontal lobe association tracts. Cortex 2012, 48(1):82-96.
120. Thivard L., Pradat P.F., Lehericy S., Lacomblez L., Dormont D., Chiras J., et al. Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: Relationships with motor disability. Journal of Neurology, Neurosurgery and Psychiatry 2007, 78(8):889-892.
121. Thompson-Schill S.L., D'Esposito M., Aguirre G., Farah M.J. Role of left inferior prefrontal cortex in retrieval of semantic knowledge: A reevaluation. Proceedings of the National Academy of Sciences USA 1997, 94(26):14792-14797.
122. Toosy A.T., Werring D.J., Orrell R.W., Howard R.S., King M.D., Barker G.J., et al. Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 2003, 74(9):1250-1257.
123. Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C., Shaw C.E., Brooks D.J., et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study. Neurobiology of Disease 2004, 15(3):601-609.
124. Turner M.R., Hammers A., Al-Chalabi A., Shaw C.E., Andersen P.M., Brooks D.J., et al. Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: Studies with [11C]flumazenil PET. Brain 2005, 128(6):1323-1329.
125. Turner M.R., Rabiner E.A., Hammers A., Al-Chalabi A., Grasby P.M., Shaw C.E., et al. [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. Brain 2005, 128(4):896-905.
126. Turner M.R., Hammers A., Al-Chalabi A., Shaw C.E., Andersen P.M., Brooks D.J., et al. Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil PET. Journal of Neurology 2007, 254(8):1033-1036.
127. 1A receptor binding in patients with homozygous D90A SOD1 vs. sporadic ALS. Neurology 2007, 68(15):1233-1235.
128. Vercelletto M., Belliard S., Wiertlewski S., Venisse T., Magne C., Duyckaerts C., et al. Neuropsychological and scintigraphic aspects of frontotemporal dementia preceding amyotrophic lateral sclerosis. Revista de Neurología 2003, 159(1):529-542.
129. Vercelletto M., Ronin M., Huvet M., Magne C., Feve J.R. Frontal type dementia preceding amyotrophic lateral sclerosis: Aneuropsychological and SPECT study of five clinical cases. European Journal of Neurology 1999, 6(3):295-299.
130. Wagner A.D., Pare-Blagoev E.J., Clark J., Poldrack R.A. Recovering meaning: Left prefrontal cortex guides controlled semantic retrieval. Neuron 2001, 31(2):329-336.
131. Wechsler I.S., Davison C. Amyotrophic lateral sclerosis with mental symptoms: A clinicopathologic study. Archives of Neurology and Psychiatry 1932, 27:859-880.
132. Whitwell J.L., Jack C.R., Senjem M.L., Josephs K.A. Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration. Neurology 2006, 66(1):102-104.
133. Wicks P., Abrahams S., Leigh P.N., Williams T., Goldstein L.H. Absence of cognitive, behavioral, or emotional dysfunction inprogressive muscular atrophy. Neurology 2006, 67(9):1718-1719.
134. Wicks P., Abrahams S., Papps B., Al-Chalabi A., Shaw C.E., Leigh P.N., et al. SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis. Journal of Neurology 2009, 256(2):234-241.
135. Wicks P., Turner M.R., Abrahams S., Hammers A., Brooks D.J., Leigh P.N., et al. Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: An (11C)-flumazenil PET study. Amyotrophic Lateral Sclerosis 2008, 9(1):43-49.
136. Wilhelmsen K.C., Forman M.S., Rosen H.J., Alving L.I., Goldman J., Feiger J., et al. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions. Archives of Neurology 2004, 61(3):398-406.
137. Wilson C.M., Grace G.M., Munoz D.G., He B.P., Strong M.J. Cognitive impairment in sporadic ALS: A pathologic continuum underlying a multisystem disorder. Neurology 2001, 57(4):651-657.
138. Zago S., Poletti B., Corbo M., Adobbati L., Silani V. Dysgraphia in patients with primary lateral sclerosis: A speech based rehearsal deficit. Behavioural Neurology 2008, 19(4):169-175.
139. Zelkowicz B.J., Herbster A.N., Nebes R.D., Mintun M.A., Becker J.T. An examination of regional cerebral blood flow during object naming tasks. Journal of the International Neuropsychological Society 1998, 4(2):160-166.
140. Ziegler L.H. Psychotic and emotional phenomena associated with amyotrophic lateral sclerosis. Archives of Neurology and Psychiatry 1930, 24(5):930-936.